| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.9 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |